Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.70
Bid: 21.70
Ask: 21.85
Change: -0.10 (-0.46%)
Spread: 0.15 (0.691%)
Open: 21.00
High: 22.10
Low: 21.00
Prev. Close: 21.80
ALL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rejection of Non-Binding Indicative Offers

15 Nov 2023 07:00

RNS Number : 4635T
Atlantic Lithium Limited
15 November 2023
 

 

15 November 2023

Atlantic Lithium rejects Non-Binding Indicative Offers from Assore

Atlantic Lithium Limited (AIM: ALL, ASX: A11, OTCQX: ALLIF, "Atlantic Lithium" or the "Company"), the African-focused lithium exploration and development company targeting to deliver Ghana's first lithium mine, announces that on 7 November 2023, the Company's major shareholder Assore International Holdings Limited ("Assore") presented a conditional and non-binding offer ("NBIO") to acquire all of the shares in the Company that it does not already own, pursuant to a scheme of arrangement, at an offer price of £0.33 per share (A$0.63).

Following careful consideration, the NBIO was rejected by the Atlantic Lithium independent board committee ("Atlantic IBC"), which was established to consider the approach from Assore. The NBIO follows an earlier approach from Assore on 2 October 2023 at an identical offer price of £0.33 per share (A$0.63; "Prior NBIO"), that was similarly rejected by the Atlantic IBC.

Shareholders of the Company do not need to take any action in respect of the NBIO or the Prior NBIO.

Rejected Offer Not Considered to be in the Best Interests of Shareholders

The Atlantic IBC and its advisers gave careful consideration to both the NBIO and Prior NBIO, and determined in each instance that it undervalued Atlantic Lithium and, therefore, was not in the best interests of shareholders, having regard to the near-term producer status of the project, the status of the pending investment from the Minerals Income Investment Fund and the positive near-term outlook for lithium project developers. 

Conditions of the Rejected NBIOs

The NBIO and Prior NBIO were both subject to a number of conditions before they would become binding, including the Atlantic Lithium board unanimously recommending the offer, providing exclusive due diligence to Assore's satisfaction, Foreign Investment Review Board approval and entry into a definitive and mutually acceptable scheme implementation agreement.

Market Cleansing

In order for the Company to cleanse the market ahead of a proposed issue of equity interests to the Minerals Income Investment Fund, as well as other potential equity issues to satisfy existing employee performance plans, Atlantic Lithium is making this announcement to provide details of the approaches received and rejected by the Atlantic IBC. Atlantic Lithium advises that the relationship with Assore remains supportive and constructive. 

There is no certainty that a further proposal will be received (from Assore or any other third party) and shareholders are cautioned not to place undue reliance upon such a proposal emerging. The Company remains focused on progressing its activities to maximise value for all shareholders.

The Company will continue to keep the market informed of any material developments in accordance with its continuous disclosure requirements.

The Atlantic IBC appointed Canaccord Genuity Limited (Australia and UK) as its financial adviser and HopgoodGanim Lawyers as its legal adviser.

Commenting, Neil Herbert, Executive Chairman of Atlantic Lithium, said:

"Assore, a major African mining company, has been a leading investor and key contributor to the Company's success since its listing in London in 2015. We look forward to maintaining our strong relationship with Assore as we progress Ewoyaa towards production."

 

The exchange rate used in this announcement is as follows:

GBP-AUD: 1.93 

 

Authorised for release by the Board of Directors of Atlantic Lithium Limited.

 

       

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

For any further information, please contact:

Atlantic Lithium Limited

Neil Herbert (Executive Chairman)

Amanda Harsas (Finance Director and Company Secretary)

www.atlanticlithium.com.au

IR@atlanticlithium.com.au

Tel: +61 2 8072 0640

SP Angel Corporate Finance LLP

Nominated Adviser

Jeff Keating

Charlie Bouverat

Tel: +44 (0)20 3470 0470

Yellow Jersey PR Limited

Charles Goodwin

Bessie Elliot atlantic@yellowjerseypr.com

Tel: +44 (0)20 3004 9512

 

Canaccord Genuity Limited

Financial Adviser:

Raj Khatri (UK) /

Duncan St John, Christian Calabrese (Australia)

 

Corporate Broking:

James Asensio

Tel: +44 (0) 20 7523 4500

 

 

Notes to Editors:

 

About Atlantic Lithium

www.atlanticlithium.com.au

Atlantic Lithium is an AIM and ASX-listed lithium company advancing a portfolio of lithium projects in Ghana and Côte d'Ivoire through to production.

The Company's flagship project, the Ewoyaa Project in Ghana, is a significant lithium spodumene pegmatite discovery on track to become Ghana's first lithium-producing mine.

The Definitive Feasibility Study for the Project indicates the production of 3.6Mt of spodumene concentrate over a 12-year mine life, making it one of the top 10 largest spodumene concentrate mines in the world.

The Project, which was awarded a Mining Lease in October 2023, is being developed under a funding agreement with Piedmont Lithium Inc.

Atlantic Lithium holds 509km2 and 774km2 of tenure across Ghana and Côte d'Ivoire respectively, comprising significantly under-explored, highly prospective licences.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCNKQBBBBDBCDD
Date   Source Headline
15th Oct 20149:47 amRNSForm 8.3 - Allocate Software plc
15th Oct 20149:47 amRNSForm 8.3 - [Allocate Software]
15th Oct 20149:21 amRNSForm 8.5 (EPT/RI)
14th Oct 20145:37 pmRNSForm 8.3 - Allocate Software PLC
14th Oct 20142:13 pmRNSFURTHER IRREVOCABLE UNDERTAKING RECEIVED
14th Oct 201411:17 amRNSForm 8 (OPD) (Acorn Bidco Limited)
14th Oct 201410:58 amRNSForm 8.3 - Allocate Software Plc
14th Oct 201410:10 amRNSReplacement Form 8 (OPD) Offeree
14th Oct 20147:06 amRNSForm 8 (OPD) Offeree
14th Oct 20147:02 amRNSRecommended Cash Offer for Allocate Software plc
26th Sep 20147:00 amRNSNew Chief Financial Officer Appointment
23rd Sep 20148:36 amRNSHolding(s) in Company
2nd Sep 20146:01 pmRNSDividend Notification
26th Aug 201410:00 amRNSFurther Amendments To Long Term Retention Plan
22nd Jul 20142:19 pmRNSHolding(s) in Company
21st Jul 20147:01 amRNSAllocate Share Options Schemes
21st Jul 20147:00 amRNSFinal Results
17th Jul 20143:55 pmRNSHolding(s) in Company
16th Jun 20147:00 amRNSTrading Update
5th Jun 20147:00 amRNSProduct Launch
9th May 20142:35 pmRNSBlocklisting Interim Review
9th May 20142:30 pmRNSBlock Listing Review
8th May 20147:00 amRNSContract Win
17th Mar 20147:00 amRNSGrant of Share Options to Directors
21st Feb 201410:56 amRNSHolding(s) in Company
21st Feb 201410:52 amRNSExercise of Share Options & Director Shareholdings
13th Feb 201412:00 pmRNSDirectorate Change
30th Jan 20147:00 amRNSContract Win
20th Jan 20147:00 amRNSInterim Results
9th Jan 20144:56 pmRNSHolding(s) in Company
16th Dec 20137:00 amRNSTrading Update
4th Dec 201312:56 pmRNSHolding(s) in Company
4th Dec 20139:00 amRNSHolding(s) in Company
28th Nov 20137:00 amRNSBoard Appointment
26th Nov 20133:27 pmRNSResult of AGM and Scrip Dividend Scheme
14th Nov 20135:34 pmRNSScrip Dividend Scheme
6th Nov 20137:00 amRNSDirector/PDMR Shareholding
4th Nov 20134:50 pmRNSBlocklisting Application
4th Nov 201311:28 amRNSDirector/PDMR Shareholding
4th Nov 201310:06 amRNSNotification of Major Interest in Shares
4th Nov 20139:29 amRNSChange of Registered Office
4th Nov 20137:00 amRNSNotification of Major Interest in Shares
28th Oct 20133:15 pmRNSDirector/PDMR Shareholding
25th Oct 20139:15 amRNSNotification of Major Interest in Shares
21st Oct 20132:17 pmRNSNotice of AGM
21st Oct 20137:00 amRNSNotification of Major Interest in Shares
8th Oct 20133:24 pmRNSDirector/PDMR Shareholding
8th Oct 201311:39 amRNSNotification of Major Interest in Shares
7th Oct 20137:11 amRNSNotification of Major Interest in Shares
7th Oct 20137:00 amRNSBlocklisting Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.